Richard Lafayette

14PUBLICATIONS
41CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 11, 2026
Humoral Response to COVID-19 Vaccines and Infection during Sibeprenlimab Treatment of IgA Nephropathy: Data from the ENVISION Trial.

|Mar 27, 2025
Expert Discussion on Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Challenges and Considerations.

Richard A Lafayette, Vivek Charu, Richard J Glassock

|Dec 26, 2024
Efficacy and Safety of Nefecon in Patients with IgA Nephropathy from Mainland China: 2-Year NefIgArd Trial Results.

Hong Zhang, Richard Lafayette, Bei Wang

|Oct 11, 2024
Safety and Efficacy of Avacopan in Patients with Complement 3 Glomerulopathy: Randomized, Double-Blind Clinical Trial.

Andrew S Bomback, Leal C Herlitz, Priyanka Punit Kedia

|Sep 27, 2024
Utilizing complement inhibition in IgA nephropathy.

Richard Lafayette

|Sep 26, 2023
Expert Discussion on Challenges in C3G Diagnosis: A Podcast Article on Best Practices in Kidney Biopsies.

Richard A Lafayette, Vivek Charu

Pageof 3

Frequent Collaborators

6 joint publications

Jonathan Barratt

2 joint publications

Vivek Charu

2 joint publications

Andrew S Bomback

2 joint publications

Leal C Herlitz